company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,77648000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,8989000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,383000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,866000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,87886000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3976000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,184000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,184000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,,totalassets,Total Assets,=,debit,usd,92046000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3760000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,685000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9369000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2096000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,15910000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,10701000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,729000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,11430000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,27340000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,208962000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-144257000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,64706000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,64706000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,64706000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2013.0,Q3,,2013-09-30,2013-11-13 06:08:16+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,92046000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,11680000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,117250000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,20120000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1154000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,150204000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3649000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,453000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,453000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,,totalassets,Total Assets,=,debit,usd,154306000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,347000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3210000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,11552000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1765000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16874000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,27491000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,617000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,28108000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,44982000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,269523000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-160218000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,19000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,109324000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,109324000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,109324000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q1,,2014-03-31,2014-05-12 16:07:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,154306000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,13059000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,127522000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,177000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1257000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,142015000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3957000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,442000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,442000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,,totalassets,Total Assets,=,debit,usd,146414000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,767000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4834000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,12237000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2319000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,20157000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,24791000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,560000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,25351000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,45508000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,270949000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-170084000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,41000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,100906000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,100906000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,100906000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q2,,2014-06-30,2014-08-07 09:36:13+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,146414000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,13128000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,116854000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,91000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1775000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,131848000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3979000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,431000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,431000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,,totalassets,Total Assets,=,debit,usd,136258000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,672000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2235000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,12287000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3106000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,18300000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,22592000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,504000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,23096000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,41396000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,271974000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-177172000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,60000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,94862000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,94862000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,94862000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2014.0,Q3,,2014-09-30,2014-11-12 07:30:38+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,136258000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,14482000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,202659000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,133000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3056000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,220330000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3830000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,409000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,409000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,,totalassets,Total Assets,=,debit,usd,224569000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,904000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2968000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,12766000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2668000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,19306000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,49978000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,516000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,50494000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,69800000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,354772000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-200034000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,31000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,154769000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,154769000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,154769000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q1,,2015-03-31,2015-05-14 06:08:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,224569000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,19096000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,188310000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,718000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2587000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,210711000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4387000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,423000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,423000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,,totalassets,Total Assets,=,debit,usd,215521000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1353000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3344000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,13320000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3094000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,21111000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,48049000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,442000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,48491000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,69602000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,357355000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-211508000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,72000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,145919000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,145919000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,145919000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q2,,2015-06-30,2015-08-07 08:00:45+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,215521000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,36956000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,146458000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1666000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5454000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,190534000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4030000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,409000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,409000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,,totalassets,Total Assets,=,debit,usd,194973000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1565000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4033000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,12862000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4280000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,22740000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,46230000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,368000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,46598000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,69338000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,361077000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-235479000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,37000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,125635000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,125635000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,125635000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2015.0,Q3,,2015-09-30,2015-11-05 06:04:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,194973000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,133011000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,348975000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1760000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6009000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,822000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,490577000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4987000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,13302000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,390000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,13692000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,,totalassets,Total Assets,=,debit,usd,509256000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1020000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4340000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,17006000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,23573000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3848000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,49787000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,28564000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,2547000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,221000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,31332000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,81119000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,380418000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,47609000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,110000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,428137000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,428137000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,428137000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q1,,2016-03-31,2016-05-06 06:04:00+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,509256000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,38154000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,431072000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3399000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6005000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1504000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,480134000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5634000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,11620000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,380000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,12000000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,,totalassets,Total Assets,=,debit,usd,497768000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,654000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8240000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,16414000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,14808000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4015000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,44131000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,24995000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,1799000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,147000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,26941000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,71072000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,392005000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,34472000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,219000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,426696000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,426696000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,426696000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q2,,2016-06-30,2016-08-05 06:11:54+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,497768000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,56375000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,384323000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2307000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7769000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,3193000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,453967000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5418000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,5327000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,414000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5741000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,,totalassets,Total Assets,=,debit,usd,465126000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,528000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9810000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,15855000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,7013000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,5931000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,39137000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,21425000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,515000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,74000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,22014000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,61151000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,388779000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,15058000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,138000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,403975000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,403975000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,403975000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2016.0,Q3,,2016-09-30,2016-11-04 06:04:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,465126000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,47184000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,333133000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5909000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8290000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,4677000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,399193000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7934000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,411000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,1543000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1954000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,,totalassets,Total Assets,=,debit,usd,409081000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,807000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,17018000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,14842000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3678000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,36345000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,14630000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1057000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,15687000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,52032000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,396121000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-38828000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-244000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,357049000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,357049000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,357049000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q1,,2017-03-31,2017-05-05 06:05:23+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,409081000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,59709000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,291009000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3832000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8754000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,363304000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,15227000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,37000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,1543000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1580000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,,totalassets,Total Assets,=,debit,usd,380111000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1321000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,15113000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,13758000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,5377000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,35569000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,13845000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,7423000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,21268000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,56837000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,406692000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-83114000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-304000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,323274000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,323274000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,323274000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q2,,2017-06-30,2017-08-08 16:17:25+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,380111000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,36448000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,284310000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4356000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8240000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,333354000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,22497000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,23000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,1543000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1566000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,,totalassets,Total Assets,=,debit,usd,357417000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2889000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,22414000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,14218000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,6202000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,45723000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,25605000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,25605000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,71328000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,412706000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-126396000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-221000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,286089000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,286089000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,286089000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2017.0,Q3,,2017-09-30,2017-11-06 16:25:53+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,357417000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,65941000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,323485000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4269000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9348000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,403043000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,30290000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3381000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3381000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,,totalassets,Total Assets,=,debit,usd,436714000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1831000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,29348000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,5799000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4188000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,41166000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,33082000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,250000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,33332000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,74498000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,537425000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-174623000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-586000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,362216000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,362216000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,362216000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q1,,2018-03-31,2018-05-08 16:18:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,436714000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,52785000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,299981000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2711000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7544000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,363021000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,30026000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3731000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3731000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,,totalassets,Total Assets,=,debit,usd,396778000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2466000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,17932000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,4706000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,5119000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,30223000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,29697000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,29697000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,59920000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,545919000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-208683000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-378000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,336858000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,336858000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,336858000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q2,,2018-06-30,2018-08-08 16:16:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,396778000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,64045000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,257551000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5015000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6246000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,332857000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,29276000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4231000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4231000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,,totalassets,Total Assets,=,debit,usd,366364000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2495000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,27167000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3043000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,6814000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,39519000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,30067000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,30067000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,69586000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,552955000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-255927000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-250000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,296778000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,296778000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,296778000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2018.0,Q3,,2018-09-30,2018-11-06 16:18:03+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,366364000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,29632000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,207325000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3363000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10221000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,250541000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,28146000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,37077000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,37077000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,,totalassets,Total Assets,=,debit,usd,315764000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3698000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4436000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12473000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3465000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,24072000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,48602000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,8764000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,57366000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,81438000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,564350000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-330066000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,42000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,234326000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,234326000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,234326000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q1,,2019-03-31,2019-05-09 16:31:28+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,315764000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,38306000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,175825000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2602000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,13282000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,230015000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,27031000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,35865000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,35865000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,,totalassets,Total Assets,=,debit,usd,292911000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3835000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3515000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,19651000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2914000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3587000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,33502000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,47597000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5200000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,52797000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,86299000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,570927000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-364457000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,142000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,206612000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,206612000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,206612000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q2,,2019-06-30,2019-08-07 20:48:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,292911000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,48933000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,137054000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3664000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7841000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,197492000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,25759000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,35289000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,35289000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,,totalassets,Total Assets,=,debit,usd,258540000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3944000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4234000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12184000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2153000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,5994000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,28509000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,46574000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5023000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,51597000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,80106000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,578881000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-400526000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,79000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,178434000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,178434000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,178434000.0
Five Prime Therapeutics Inc,FPRX,549300Z652HXXGMB7V71,0001175505,2019.0,Q3,,2019-09-30,2019-11-06 17:16:00+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,258540000.0
